P028 | SUBCORTICAL MARKERS OF EARLY PROGRESSION IN AMYLOID-POSITIVE UNIMPAIRED INDIVIDUALS
European Journal of Histochemistry · 20.11.2026 · 70 (s2)
DOI: 10.4081/ejh.2026.4848 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, online erschienen am 20.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Subcortical neuromodulatory nuclei may be affected early in Alzheimer’s disease, but their structural and functional associations with amyloid positivity and subsequent clinical worsening remain incompletely characterized. We investigated whether regional morphometric signals and functional connectivity distinguish amyloid-positive individuals who remain clinically stable from those showing near-term worsening. We analyzed data from the European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD-LCS). The structural sample comprised 50 amyloid-negative participants, 50 stable amyloid-positive participants and 33 amyloid-positive participants whose global Clinical Dementia Rating (CDR) increased from zero to 0.5 within 6-12 months. The first two groups were selected to match the third for age and sex. Atlas-defined grey-matter signal in the nucleus basalis of Meynert (NbM), ventral tegmental area (VTA), substantia nigra (SN), locus coeruleus (LC) and dorsal raphe (DR) nucleus was examined at baseline and follow-up; 23 participants with subsequent clinical worsening had follow-up structural scans. Baseline resting-state functional imaging was available for 25, 35 and 16 participants, respectively. Seed-based and neurotransmitter-enriched connectivity were assessed, together with exploratory cross-sectional associations with cerebrospinal fluid ptau-181. After adjustment for scanner manufacturer, magnetic field strength and other covariates, no structural group differences survived correction for multiple comparisons. Participants with subsequent clinical worsening differed from amyloid-negative controls in connectivity involving midbrain dopaminergic and DR regions, as well as serotonin receptor-enriched networks. Within the amyloid-positive sample, clinically stable and worsening participants differed in LC and NbM connectivity. Noradrenaline transporter-enriched connectivity also differed between stable amyloid-positive and amyloid-negative participants. Cerebrospinal fluid ptau-181 concentrations were associated with LC, VTA and dopamine receptor type 1-enriched connectivity. Functional connectivity measures thus differed across amyloid-defined groups with distinct subsequent CDR trajectories. Together, these findings highlight the potential of subcortical functional connectivity to characterize early clinical heterogeneity in amyloid-positive individuals and provide a rationale for its prospective evaluation
Zitieren
APA
(2026). P028 | SUBCORTICAL MARKERS OF EARLY PROGRESSION IN AMYLOID-POSITIVE UNIMPAIRED INDIVIDUALS. European Journal of Histochemistry, 70(s2). https://doi.org/10.4081/ejh.2026.4848
Vancouver
P028 | SUBCORTICAL MARKERS OF EARLY PROGRESSION IN AMYLOID-POSITIVE UNIMPAIRED INDIVIDUALS. European Journal of Histochemistry. 2026;70(s2). doi:10.4081/ejh.2026.4848
BibTeX
@article{euvimed2026,
title = {P028 | SUBCORTICAL MARKERS OF EARLY PROGRESSION IN AMYLOID-POSITIVE UNIMPAIRED INDIVIDUALS},
journal = {European Journal of Histochemistry},
year = {2026},
volume = {70},
number = {s2},
doi = {10.4081/ejh.2026.4848}
}
EUVIMED